eBook

Recommendations for Adopting New Approach Methodologies to Reduce Animal Testing in Drug Development

Discover advanced regulatory writing strategies, global regulatory submission best practices, eCTD guidance, ICH M15 updates…

Certara2026年7月7日

On-Demand Webinar

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

Learn how PBPK and QSP modeling support faster drug development by enabling smarter dose selection,…

Certara2026年7月1日

On-Demand Webinar

IND申請と資金調達に向けた開発プログラムの構築

Learn how emerging biotechs can build IND-ready, investor-ready development programs using Totality of Evidence, NAMs,…

Certara2026年6月15日

On-Demand Webinar

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

Learn how PBPK and QSP modeling support regulatory confidence, accelerate drug development, and align with…

Certara2026年5月26日

Press Coverage

FDA Rebuilding After DOGE Cuts: Former Regulators Speak Out

Former FDA officials describe the impact of DOGE-era staffing cuts, lost expertise, and the challenges…

Certara2026年5月15日

Guide

How to Leverage PBPK Modeling and Simulation in Drug Research and Development

Learn how PBPK modeling and simulation in drug research and development reduces clinical burden, supports…

Certara2026年5月12日

On-Demand Webinar

BioSpace webinar: Streamlining Nonclinical Development with FDA NAMs

Learn how to apply FDA NAM guidance to streamline nonclinical development, support IND decisions, and…

Certara2026年5月8日

Blog

医薬品企業が治験薬の非動物試験へ移行するための方法

Pharma companies can ease the transition to non-animal studies for investigational drugs by leveraging NAMs…

Certara2026年5月5日

Blog

From models to impact: What QSPC 2026 revealed about the future of drug development

Explore Certara’s insights from QSPC 2026, including virtual patients, regulatory adoption, AI in QSP, and…

Certara2026年4月28日

Fact Sheet

ToxStudio® Predictive Toxicology Software

Learn about ToxStudio: Predictive toxicology software to support prediction of drug-induced liver injury (DILI), QT…

Certara2026年4月16日

New Approach Methodologies (NAMs)

Recommendations for Adopting New Approach Methodologies to Reduce Animal Testing in Drug Development

The Power of Modeling: Speed, Early De-Risking, and Regulatory Success for Forward-Thinking Sponsors

IND申請と資金調達に向けた開発プログラムの構築

The Modeling Advantage: How Forward-Thinking Sponsors Are Moving Faster, De-Risking Earlier, and Winning with Regulators

FDA Rebuilding After DOGE Cuts: Former Regulators Speak Out

How to Leverage PBPK Modeling and Simulation in Drug Research and Development

BioSpace webinar: Streamlining Nonclinical Development with FDA NAMs

医薬品企業が治験薬の非動物試験へ移行するための方法

From models to impact: What QSPC 2026 revealed about the future of drug development

ToxStudio® Predictive Toxicology Software

メルマガ登録

クイックアクセス

ソリューション

お問合せ